Sep 5, 2018
This week in our Your Stock, Our Take segment we look at Covalon Technologies Ltd. (COV:TSX-V), a researcher, developer, manufacturer, and marketer of patent-protected medical products that improve patient outcomes and save lives in the areas of advanced wound care, infection management and surgical procedures. This week, the company announced record Q2 results and a listener asks us if we would still BUY the stock. Our Star of the week is XPEL Inc. (DAP.U:TSX-V), manufactures, sells and distributes, and installs after-market automotive products, including automotive paint protection film, headlight protection film, automotive window films and other related products. The stock jumped 22% this week on very strong Q2 financial results and is now up 400% in 2018. Finally, our Dog of the week is Cronos Group Inc. (CRON:TSX) – is a vertically integrated cannabis company with a presence across four continents. The company operates two wholly-owned Canadian licensed producers regulated under Health Canada's Access to Cannabis for Medical Purposes Regulations. While there has been a number of high flyers in this segment of late, Cronos was hit by a short report today and shares plummeted 28% on the day. Is it a Dog or an opportunity?

Sign up for the Stock Talk Podcast

Be the first to find out the latest Keystone Financial news, special reports, receive our Stock Talk Podcast, DIY Seminar event info, and Your Stock Our Take videos directly to your inbox for free.